Drug Testing Companies
DOJ
False Claims Act
Penalty
$1.7 million
Outcome
Drug Testing Companies Agree To Collectively Pay $1.7 Million to Resolve False Claims Act Allegations
Details
Drug Testing Companies — DOJ Enforcement (2023)
DOJ took enforcement action against Drug Testing Companies in KY in 2023 involving false claims act violations in the Physician Practices sector.
Penalty: $1.7 million
Violation types: False Claims Act
Entity type: Physician Practice
Penalty type: Settlement
Location: KY
Source: DOJ Press Release — Drug Testing Companies Agree To Collectively Pay $1.7 Million to Resolve False Claims Act Allegations
How Crucible Prevents This
Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works